Ramkumar Rajamani

Ramkumar Rajamani is the Executive Director at Eli Lilly and Company, a position held since 2021. Prior to this role, Ramkumar worked as a Senior Principal Scientist at Xenon Pharmaceuticals Inc. and a Senior Research Investigator II at Bristol Myers Squibb from 2005 to 2020. Ramkumar also completed a postdoctoral fellowship at Johnson & Johnson from 2003 to 2005. They earned a Doctor of Philosophy (Ph.D.) in Computational Chemistry from the University of Minnesota-Twin Cities and are currently pursuing a Master's degree at the University of Miami.